Instil Bio, Inc. - Common Stock, $0.000001 par value per share (TIL)

CUSIP: 45783C101

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / Common Stock, $0.000001 par value per share
Shares outstanding
6,795,789
Total 13F shares
1,899,004
Share change
0
Total reported value
$19,540,751
Price per share
$10.29
Number of holders
1

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 45783C101?
CUSIP 45783C101 identifies TIL - Instil Bio, Inc. - Common Stock, $0.000001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of TIL - Instil Bio, Inc. - Common Stock, $0.000001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Curative Ventures V LLC
13F
Company
28%
1,899,004
$20,509,243 31 Mar 2024
13F
Vivo Capital, LLC
13F
Company
9.6%
624,338
$6,742,850 31 Mar 2024
13F
CPMG Inc
13F
Company
6.3%
410,922
$4,437,958 31 Mar 2024
13F
BML Capital Management, LLC
13F
Company
5.4%
348,735
$3,766,338 31 Mar 2024
13F
Cable Car Capital, LP
13F
Company
4%
258,097
$2,787,448 31 Mar 2024
13F
VANGUARD GROUP INC
13F
Company
2%
129,513
$1,398,740 31 Mar 2024
13F
Nantahala Capital Management, LLC
13F
Company
2%
127,292
$1,374,754 31 Mar 2024
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
1.9%
126,255
$1,364,000 31 Mar 2024
13F
BlackRock Finance, Inc.
13F
Company
0.94%
61,019
$659,005 31 Mar 2024
13F
MARSHALL WACE, LLP
13F
Company
0.93%
60,626
$654,760 31 Mar 2024
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.68%
44,400
$479,520 31 Mar 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.53%
34,752
$375,424 31 Mar 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.48%
31,381
$338,915 31 Mar 2024
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.45%
29,489
$318,481 31 Mar 2024
13F
Squarepoint Ops LLC
13F
Company
0.27%
17,367
$187,564 31 Mar 2024
13F
CITADEL ADVISORS LLC
13F
Company
0.24%
15,438
$166,730 31 Mar 2024
13F
STATE STREET CORP
13F
Company
0.18%
11,682
$126,166 31 Mar 2024
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
0.16%
10,244
$109,000 31 Mar 2024
13F
MORGAN STANLEY
13F
Company
0.09%
5,587
$60,340 31 Mar 2024
13F
BARCLAYS PLC
13F
Company
0.01%
479
$5,173 31 Mar 2024
13F
Tower Research Capital LLC (TRC)
13F
Company
0%
274
$2,959 31 Mar 2024
13F
UBS Group AG
13F
Company
0%
259
$2,798 31 Mar 2024
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0%
178
$1,922 31 Mar 2024
13F
RHUMBLINE ADVISERS
13F
Company
0%
114
$1,231 31 Mar 2024
13F
Lindbrook Capital, LLC
13F
Company
0%
68
$734 31 Mar 2024
13F
WELLS FARGO & COMPANY/MN
13F
Company
0%
31
$335 31 Mar 2024
13F
Frazier Financial Advisors, LLC
13F
Company
0%
15
$162 31 Mar 2024
13F
OSAIC HOLDINGS, INC.
13F
Company
0%
13
$140 31 Mar 2024
13F
CITIGROUP INC
13F
Company
0%
2
$22 31 Mar 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
1
$11 31 Mar 2024
13F
Qube Research & Technologies Ltd
13F
Company
0%
1
$11 31 Mar 2024
13F
Timothy L. Moore
3/4/5
Chief Operating Officer
class O/S missing
750,000
06 Sep 2022
Zachary Roberts
3/4/5
Chief Medical Officer
class O/S missing
245,000
04 Mar 2022
Vijay Chiruvolu
3/4/5
Chief Technical Officer
class O/S missing
154,237
20 May 2022
Sumita Ray
3/4/5
Chief Legal and Admin Officer
class O/S missing
50,000
08 Jan 2023
Jack Nielsen
3/4/5
Director
class O/S missing
1,500
14 Jun 2023

Institutional Holders of Instil Bio, Inc. - Common Stock, $0.000001 par value per share (TIL) as of Q2 2024

As of 30 Jun 2024, Instil Bio, Inc. - Common Stock, $0.000001 par value per share (TIL) was held by 1 institutional shareholder that filed Form 13F with the SEC. Together, they reported ownership of 1,899,004 shares. The largest 1 holders included Curative Ventures V LLC. This page lists 1 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders
1
Q2 2024 holders
1
Holder diff
0
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 Value $ Q2 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.